Poulton Stuart 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Poulton Stuart（CIK 1942597）在 1 家公司共报告 10 笔 SEC Form 4 内部人交易（最近一笔 2026-07-30）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-07-30 | Karyopharm Therapeutics Inc. (KPTI) | EVP, Chief Development Officer | 卖出 | 189 | $1,342 |
| 2026-05-15 | Karyopharm Therapeutics Inc. (KPTI) | EVP, Chief Development Officer | 买入 | 896 | $0 |
| 2026-05-15 | Karyopharm Therapeutics Inc. (KPTI) | EVP, Chief Development Officer | 卖出 | 403 | $3,828 |
| 2026-03-03 | Karyopharm Therapeutics Inc. (KPTI) | EVP, Chief Development Officer | 卖出 | 5,101 | $48,000 |
| 2026-02-19 | Karyopharm Therapeutics Inc. (KPTI) | EVP, Chief Development Officer | 卖出 | 378 | $3,262 |
| 2026-02-03 | Karyopharm Therapeutics Inc. (KPTI) | EVP, Chief Development Officer | 买入 | 32,415 | $0 |
| 2025-10-16 | Karyopharm Therapeutics Inc. (KPTI) | EVP, Chief Development Officer | 买入 | 39,682 | $0 |
| 2025-09-16 | Karyopharm Therapeutics Inc. (KPTI) | EVP, Chief Development Officer | 买入 | 888 | $0 |
| 2025-09-16 | Karyopharm Therapeutics Inc. (KPTI) | EVP, Chief Development Officer | 卖出 | 401 | $2,578 |
| 2025-07-30 | Karyopharm Therapeutics Inc. (KPTI) | EVP, Chief Development Officer | 卖出 | 191 | $835 |
来源：SEC Form 4 申报文件 · 截至 2026-07-30